APA

Moilanen A., Riikonen R., Oksala R., Ravanti L., Aho E., Wohlfahrt G., Nykänen P. S., Törmäkangas O. P., Palvimo J. J. & Kallio P. J. (20160804). Discovery of ODM-201, a new-generation androgen receptor inhibitor targeting resistance mechanisms to androgen signaling-directed prostate cancer therapies. : Scientific reports.

Chicago

Moilanen Anu-Maarit, Riikonen Reetta, Oksala Riikka, Ravanti Laura, Aho Eija, Wohlfahrt Gerd, Nykänen Pirjo S, Törmäkangas Olli P, Palvimo Jorma J and Kallio Pekka J. 20160804. Discovery of ODM-201, a new-generation androgen receptor inhibitor targeting resistance mechanisms to androgen signaling-directed prostate cancer therapies. : Scientific reports.

Harvard

Moilanen A., Riikonen R., Oksala R., Ravanti L., Aho E., Wohlfahrt G., Nykänen P. S., Törmäkangas O. P., Palvimo J. J. and Kallio P. J. (20160804). Discovery of ODM-201, a new-generation androgen receptor inhibitor targeting resistance mechanisms to androgen signaling-directed prostate cancer therapies. : Scientific reports.

MLA

Moilanen Anu-Maarit, Riikonen Reetta, Oksala Riikka, Ravanti Laura, Aho Eija, Wohlfahrt Gerd, Nykänen Pirjo S, Törmäkangas Olli P, Palvimo Jorma J and Kallio Pekka J. Discovery of ODM-201, a new-generation androgen receptor inhibitor targeting resistance mechanisms to androgen signaling-directed prostate cancer therapies. : Scientific reports. 20160804.